Literature DB >> 20967840

Socioeconomic status and risk of hospitalization among individuals with cystic fibrosis in Ontario, Canada.

Anne Stephenson1, Janet Hux, Elizabeth Tullis, Peter C Austin, Mary Corey, Joel Ray.   

Abstract

BACKGROUND: Socioeconomic status (SES) is a strong predictor of outcomes in cystic fibrosis (CF); however, there are no published studies evaluating this relationship in Canadians with CF. The objective of this study was to assess the effect of SES on annual hospitalization rates in a large cohort of pediatric and adult CF subjects under a universal health care system.
METHODS: A population-based longitudinal study was completed in Ontario from 1993 to 2002 using a comprehensive CF registry containing patient-level data, linked to provincial health care administrative databases. Income quintiles were derived at the neighborhood level using postal code information and Statistics Canada census data. The effect of income quintile on the annual hospitalization rate for respiratory-related illness was estimated by Poisson regression using generalized estimating equations, and was expressed as a rate ratio (RR) and 95% confidence interval (CI). The analysis was adjusted for age, sex, lung function, nutritional status, the presence of diabetes, area of residence, and distance between the subject's residence and the reporting CF centre.
RESULTS: A total of 1,174 participants over the age of 6 years contributed 8,444 patient-years of data. No statistically significant differences in annual hospitalization rates for respiratory-related causes were found between the lowest and highest income quintiles (adjusted RR 1.17 [95% CI 0.96-1.43]). The effect of income quintile remained non-significant across a majority of markers of CF disease severity and across a range of subgroups.
CONCLUSIONS: After adjusting for important covariates, no SES-disparities in hospitalization rates were found in a large Canadian pediatric and adult CF cohort. It may be the distinctive combination of universal health care, a national network of specialty CF clinics, and drug and travel coverage available in Ontario that results in similar hospitalization rates regardless of SES.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20967840     DOI: 10.1002/ppul.21368

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  15 in total

Review 1.  Socioeconomic determinants of respiratory health in patients with cystic fibrosis: implications for treatment strategies.

Authors:  Gabriela R Oates; Michael S Schechter
Journal:  Expert Rev Respir Med       Date:  2022-06-23       Impact factor: 4.300

2.  Cost-of-illness analysis and regression modeling in cystic fibrosis: a retrospective prevalence-based study.

Authors:  Tomáš Mlčoch; Jiří Klimeš; Libor Fila; Věra Vávrová; Veronika Skalická; Marek Turnovec; Veronika Krulišová; Jitka Jirčíková; Dana Zemková; Klára Vilimovská Dědečková; Alena Bílková; Vladimíra Frühaufová; Lukáš Homola; Zuzana Friedmannová; Radovan Drnek; Pavel Dřevínek; Tomáš Doležal; Milan Macek
Journal:  Eur J Health Econ       Date:  2016-01-07

3.  Respiratory pathogens mediate the association between lung function and temperature in cystic fibrosis.

Authors:  Joseph M Collaco; Karen S Raraigh; Lawrence J Appel; Garry R Cutting
Journal:  J Cyst Fibros       Date:  2016-06-11       Impact factor: 5.482

Review 4.  The demographics of adverse outcomes in cystic fibrosis.

Authors:  Meghan E McGarry; Wadsworth A Williams; Susanna A McColley
Journal:  Pediatr Pulmonol       Date:  2019-11

5.  Effect of temperature on cystic fibrosis lung disease and infections: a replicated cohort study.

Authors:  Joseph M Collaco; John McGready; Deanna M Green; Kathleen M Naughton; Christopher P Watson; Timothy Shields; Scott C Bell; Claire E Wainwright; Garry R Cutting
Journal:  PLoS One       Date:  2011-11-18       Impact factor: 3.240

6.  Survival and Lung Transplant Outcomes for Individuals With Advanced Cystic Fibrosis Lung Disease Living in the United States and Canada: An Analysis of National Registries.

Authors:  Kathleen J Ramos; Jenna Sykes; Sanja Stanojevic; Xiayi Ma; Joshua S Ostrenga; Aliza Fink; Bradley S Quon; Bruce C Marshall; Albert Faro; Kristofer Petren; Alexander Elbert; Christopher H Goss; Anne L Stephenson
Journal:  Chest       Date:  2021-04-17       Impact factor: 10.262

7.  The health care cost of dying: a population-based retrospective cohort study of the last year of life in Ontario, Canada.

Authors:  Peter Tanuseputro; Walter P Wodchis; Rob Fowler; Peter Walker; Yu Qing Bai; Sue E Bronskill; Douglas Manuel
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

8.  Critical care at the end of life: a population-level cohort study of cost and outcomes.

Authors:  Dipayan Chaudhuri; Peter Tanuseputro; Brent Herritt; Gianni D'Egidio; Mathieu Chalifoux; Kwadwo Kyeremanteng
Journal:  Crit Care       Date:  2017-05-31       Impact factor: 9.097

9.  Do children with cystic fibrosis receiving outreach care have poorer clinical outcomes than those treated at a specialist cystic fibrosis centre?

Authors:  Heinrich C Weber; Philip F Robinson; Nicole Saxby; Sean A Beggs; Ingrid Els; Rodney I Ehrlich
Journal:  Aust J Rural Health       Date:  2016-11-17       Impact factor: 1.662

10.  Evaluating Adult Cystic Fibrosis Care in BC: Disparities in Access to a Multidisciplinary Treatment Centre.

Authors:  James M Roberts; Pearce G Wilcox; Bradley S Quon
Journal:  Can Respir J       Date:  2016-02-29       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.